Pdt Partners, LLC Keros Therapeutics, Inc. Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$41.44 - $59.32 $2,320 - $3,321	56 Added 0.25%	22,657 $967,000
Q4 2022 Feb 14, 2023	SELL	$39.45 - $51.77 $2,445 - $3,209	-62 Reduced 0.27%	22,601 $1.09 Million
Q3 2022 Nov 14, 2022	SELL	$27.8 - $40.12 $691,747 - $998,305	-24,883 Reduced 52.33%	22,663 $853,000
Q2 2022 Aug 15, 2022	BUY	$26.03 - $67.04 $791,077 - $2.04 Million	30,391 Added 177.16%	47,546 $1.31 Million
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $722,568 - $1.02 Million	17,155 New	17,155 $933,000
Q2 2021 Aug 16, 2021	SELL	$42.4 - $70.11 $164,342 - $271,746	-3,876 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$54.0 - $75.28 $209,304 - $291,785	3,876 New	3,876 $239,000

174

30.3M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.44B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.